Huma Ltd

Largest decentralized study of its kind shows high levels of engagement with Huma’s study app

A new study involving Huma's clinical trial platform showed that participants had a positive experience using the app to report measurements and symptoms. The study found sustained levels of engagement over 6 months, with only 2.5% of participants withdrawing.

SourceHuma Ltd·JournalJournal of Medical Internet Research·TypeObservational study·DateJan 13, 2023

Largest decentralized study of its kind shows high levels of engagement with Huma’s study app

A new study published in the Journal of Medical Internet Research found that participants using Huma's clinical trial platform had an average engagement rate of 34.5 weeks and a high retention rate, with only 2.5% withdrawing from the study. The study highlights the potential of digital health solutions for population-based research.

SourceHuma Ltd·JournalJournal of Medical Internet Research·TypeObservational study·DateJan 13, 2023